GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0034475
|
BP
|
U4 snRNA 3'-end processing
|
Any process involved in forming the mature 3' end of a U4 snRNA molecule.
|
EXOSC9,
EXOSC2,
EXOSC7,
EXOSC6,
EXOSC8,
EXOSC4,
EXOSC3
|
GO:0034476
|
BP
|
U5 snRNA 3'-end processing
|
Any process involved in forming the mature 3' end of a U5 snRNA molecule.
|
EXOSC9,
EXOSC7,
EXOSC8
|
GO:0034497
|
BP
|
protein localization to pre-autophagosomal structure
|
Any process in which a protein is transported to, or maintained at, the pre-autophagosomal structure (PAS).
|
MFN2,
WIPI1,
PIK3C3,
WDR45,
WIPI2
|
GO:0034498
|
BP
|
early endosome to Golgi transport
|
The directed movement of substances from early endosomes to the Golgi.
|
TRAPPC10,
SNX1,
EHD3
|
GO:0034501
|
BP
|
protein localization to kinetochore
|
Any process in which a protein is transported to, or maintained at, the kinetochore.
|
BUB1B,
CDK1,
CASC5,
SPDL1,
AURKB,
CHAMP1
|
GO:0034502
|
BP
|
protein localization to chromosome
|
Any process in which a protein is transported to, or maintained at, a specific location on a chromosome.
|
TEX15
|
GO:0034504
|
BP
|
protein localization to nucleus
|
A process in which a protein is transported to, or maintained in, a location within the nucleus.
|
TOR1A,
XPO1,
PLRG1,
DNAJB6,
CTDNEP1,
COL1A1,
LMNA,
BMP4,
CALR,
SOX9,
RPL11,
MDM2,
HHEX,
ZBTB16,
CNEP1R1,
BANP,
SYNE2,
PIKFYVE
|
GO:0034505
|
BP
|
tooth mineralization
|
The process in which calcium salts are deposited into calcareous tooth structures such as dental enamel, dentin and cementum.
|
COL1A1
|
GO:0034508
|
BP
|
centromere complex assembly
|
The aggregation, arrangement and bonding together of proteins and centromeric DNA molecules to form a centromeric protein-DNA complex. Includes the formation of the chromatin structures which form a platform for the kinetochore, and assembly of the kinetochore onto this specialized chromatin. In fission yeast and higher eukaryotes this process also includes the formation of heterochromatin at the outer repeat (pericentric) regions of the centromere.
|
CENPV
|
GO:0034516
|
BP
|
response to vitamin B6
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B6 stimulus. Vitamin B6 encompasses pyridoxal, pyridoxamine and pyridoxine and the active form, pyridoxal phosphate.
|
KYNU
|
GO:0034551
|
BP
|
mitochondrial respiratory chain complex III assembly
|
The aggregation, arrangement and bonding together of a set of components to form the cytochrome bc(1) complex (also known as ubiquinol-cytochrome c reductase), in the mitochondrial inner membrane.
|
UQCRB,
TTC19,
UQCC3,
UQCC2,
UQCR10,
BCS1L
|
GO:0034587
|
BP
|
piRNA metabolic process
|
The chemical reactions and pathways involving piRNAs, Piwi-associated RNAs, a class of 24- to 30-nucleotide RNA derived from repeat or complex DNA sequence elements and processed by a Dicer-independent mechanism.
|
PIWIL4,
TDRD9
|
GO:0034589
|
BP
|
hydroxyproline transport
|
The directed movement of hydroxyproline into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
SLC1A4
|
GO:0034599
|
BP
|
cellular response to oxidative stress
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
FOXO3,
PRKRA,
STAU1,
PENK,
GPX1,
PARP1,
HSPA1A,
HSPA1B,
G6PD,
ATP2A2,
NME2,
MT3,
PRDX2,
SNCA,
ETV5,
NR4A2,
SESN2,
FOXO1,
HDAC1,
NFE2L1,
PRKD1,
ADNP2,
SETX,
CPEB2,
SIRT2,
PNPT1,
TXN2,
VIMP,
PINK1,
FANCD2,
ATP13A2,
SEPN1,
PPARGC1A
|
GO:0034605
|
BP
|
cellular response to heat
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
|
TFEC,
PDCD6,
IL1A,
EIF2S1,
LYN,
THBS1,
HMOX1,
HSPA1A,
HSPA1B,
TPR,
HSPA6,
CDKN1A,
MKI67,
IRAK1,
ATXN3,
HSF1,
C11orf73,
TRPV1,
HDAC2,
STAC,
TRPV4,
SLC52A3,
ARPP21
|
GO:0034612
|
BP
|
response to tumor necrosis factor
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
|
ADAM10,
MAP2K7,
UBD,
JAK2,
CD14,
SELE,
PTGS2,
CHI3L1,
AFF3,
IGBP1,
ADAM9,
RIPK1,
CASP8,
ADIPOQ,
MAP4K3,
CXCL16,
YTHDC2,
NUB1,
TNFRSF11A
|
GO:0034613
|
BP
|
cellular protein localization
|
Any process in which a protein is transported to, and/or maintained in, a specific location at the level of a cell. Localization at the cellular level encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell.
|
RAP2A,
DMD,
CTNNA1,
WNT5A,
ID4,
CSNK1E,
NLRP5,
CDC42,
ANK2,
KCNA1,
AMOT,
LAMTOR1,
NIPBL,
AHI1,
AJUBA,
FRMD6,
RRAGC,
RRAGD,
LATS2,
ARMCX3,
LAMTOR3,
PRPF19,
LAMTOR2
|
GO:0034614
|
BP
|
cellular response to reactive oxygen species
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
|
FOS,
TPM1,
PDGFRA,
MPV17,
AKR1C3,
ROMO1,
PKD2,
PTPRK,
PPARGC1B
|
GO:0034616
|
BP
|
response to laminar fluid shear stress
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers. As an example, laminar shear stress can be seen where blood flows against the luminal side of blood vessel walls.
|
SMAD7,
SMAD6,
ABCA1,
TGFB1,
ETS1,
ADAM9
|
GO:0034620
|
BP
|
cellular response to unfolded protein
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus.
|
PARK2,
RHBDD1,
PACRG
|
GO:0034625
|
BP
|
fatty acid elongation, monounsaturated fatty acid
|
Elongation of a fatty acid chain into which one C-C double bond has been introduced.
|
ELOVL7,
ELOVL1,
ELOVL4,
ELOVL6,
ELOVL5
|
GO:0034626
|
BP
|
fatty acid elongation, polyunsaturated fatty acid
|
Elongation of a fatty acid chain into which two or more C-C double bonds have been introduced.
|
ELOVL7,
ELOVL1,
ELOVL4,
ELOVL6,
ELOVL5
|
GO:0034628
|
BP
|
de novo' NAD biosynthetic process from aspartate
|
The chemical reactions and pathways resulting in the formation of nicotinamide adenine dinucleotide (NAD), beginning with the synthesis of aspartate from simpler precursors; biosynthesis may be of either the oxidized form, NAD, or the reduced form, NADH.
|
NMNAT3
|
GO:0034629
|
BP
|
cellular protein complex localization
|
A protein complex localization process that takes place at the cellular level; as a result, a protein complex is transported to, or maintained in, a specific location within a cell.
|
WASL,
SMAD7,
SNAPIN,
EZR,
DLG1,
SEH1L
|
GO:0034633
|
BP
|
retinol transport
|
The directed movement of retinol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Retinol is vitamin A1, 2,6,6-trimethyl-1-(9'-hydroxy-3',7'-dimethylnona-1',3',5',7'-tetraenyl)cyclohex-1-ene, one of the three components that makes up vitamin A.
|
RBP4
|
GO:0034638
|
BP
|
phosphatidylcholine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.
|
ENPP2,
PNPLA8
|
GO:0034644
|
BP
|
cellular response to UV
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.
|
TRIAP1,
KDM1A,
N4BP1,
MYC,
TP53,
EIF2S1,
PCNA,
ATF4,
YY1,
PIK3R1,
POLD1,
CDC25A,
PTGS2,
CASP9,
FMR1,
BAX,
EP300,
NFATC4,
PTPRK,
RHBDD1,
CREBBP,
ERCC4,
TP53INP1,
AURKB,
PBK,
USP28,
RHNO1,
EIF2AK4,
RUVBL2,
NOC2L
|
GO:0034645
|
BP
|
cellular macromolecule biosynthetic process
|
The chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass, carried out by individual cells.
|
PTH
|
GO:0034650
|
BP
|
cortisol metabolic process
|
The chemical reactions and pathways involving cortisol, the steroid hormone 11-beta-17,21-trihydroxypregn-4-ene-3,20-dione. Cortisol is synthesized from cholesterol in the adrenal gland and controls carbohydrate, fat and protein metabolism and has anti-inflammatory properties.
|
CYP11A1
|
GO:0034651
|
BP
|
cortisol biosynthetic process
|
The chemical reactions and pathways resulting in the formation of cortisol, the steroid hormone 11-beta-17,21-trihydroxypregn-4-ene-3,20-dione. Cortisol is synthesized from cholesterol in the adrenal gland and controls carbohydrate, fat and protein metabolism and has anti-inflammatory properties.
|
CYP11B1,
CYP11B2
|
GO:0034653
|
BP
|
retinoic acid catabolic process
|
The chemical reactions and pathways resulting in the breakdown of retinoic acid, one of the three components that makes up vitamin A.
|
CYP26A1,
CYP26B1
|
GO:0034656
|
BP
|
nucleobase-containing small molecule catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a nucleobase-containing small molecule: a nucleobase, a nucleoside, or a nucleotide.
|
NUDT1,
NUDT16,
NUDT9,
NUDT15,
NUDT5
|
GO:0034670
|
BP
|
chemotaxis to arachidonic acid
|
The directed movement of a motile cell or organism in response to the presence of arachidonic acid.
|
CREB1
|
GO:0034695
|
BP
|
response to prostaglandin E
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus.
|
GNRH1,
TGFBR3
|
GO:0034696
|
BP
|
response to prostaglandin F
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin F stimulus.
|
EDN1,
YY1
|
GO:0034698
|
BP
|
response to gonadotropin
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gonadotropin stimulus.
|
ICAM1,
ITGA3
|
GO:0034699
|
BP
|
response to luteinizing hormone
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a luteinizing hormone stimulus.
|
TGFBR3
|
GO:0034720
|
BP
|
histone H3-K4 demethylation
|
The modification of histone H3 by the removal of a methyl group from lysine at position 4 of the histone.
|
KDM1A,
KDM5A,
KDM5B
|
GO:0034721
|
BP
|
histone H3-K4 demethylation, trimethyl-H3-K4-specific
|
The modification of histone H3 by the removal of a methyl group from a trimetylated lysine at position 4 of the histone.
|
KDM5B
|
GO:0034755
|
BP
|
iron ion transmembrane transport
|
A process in which an iron ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
|
TTYH1,
SLC40A1
|
GO:0034763
|
BP
|
negative regulation of transmembrane transport
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a solute from one side of a membrane to the other.
|
CTTNBP2NL
|
GO:0034765
|
BP
|
regulation of ion transmembrane transport
|
Any process that modulates the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other.
|
GPR89A,
CLIC1,
WWP2,
CACNA1G,
CLIC3,
CYBB,
GPR89B,
KCNA1,
KCNMA1,
KCNC3,
KCNJ12,
SCN9A,
CACNA1E,
ASIC2,
TPCN2,
KCNG3,
KCNV2,
KCNE4,
TMEM37,
CLIC6,
NEDD4L,
KCNK17,
CACNG6,
KCNK12,
CLIC5,
KCNK6
|
GO:0034767
|
BP
|
positive regulation of ion transmembrane transport
|
Any process that activates or increases the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other.
|
ANO6
|
GO:0034769
|
BP
|
basement membrane disassembly
|
The controlled breakdown of the basement membrane in the context of a normal process such as imaginal disc eversion.
|
CTSS
|
GO:0034770
|
BP
|
histone H4-K20 methylation
|
The modification of histone H4 by addition of one or more methyl groups to lysine at position 20 of the histone.
|
WHSC1,
KMT5A
|
GO:0034773
|
BP
|
histone H4-K20 trimethylation
|
The modification of histone H4 by addition of three methyl groups to lysine at position 20 of the histone.
|
PWP1,
KMT5B,
ARID4B,
KMT5C
|
GO:0034776
|
BP
|
response to histamine
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a histamine stimulus. Histamine, the biogenic amine 2-(1H-imidazol-4-yl)ethanamine, is involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter.
|
DRD2
|
GO:0034959
|
BP
|
endothelin maturation
|
The process leading to the attainment of the full functional capacity of endothelin by conversion of Big-endothelin substrate into mature endothelin.
|
ECE1
|
GO:0034968
|
BP
|
histone lysine methylation
|
The modification of a histone by addition of one or more methyl groups to a lysine residue.
|
PRDM2,
SETD6,
SETD7,
EHMT2,
WHSC1L1,
SMYD3,
PRDM6
|
GO:0034969
|
BP
|
histone arginine methylation
|
The modification of a histone by addition of a methyl group to an arginine residue.
|
PRMT3
|
GO:0034970
|
BP
|
histone H3-R2 methylation
|
The modification of histone H3 by addition of a methyl group to arginine at position 2 of the histone.
|
CARM1,
PRMT6
|
GO:0034971
|
BP
|
histone H3-R17 methylation
|
The modification of histone H3 by addition of a methyl group to arginine at position 17 of the histone.
|
CARM1,
NR1H4
|
GO:0034975
|
BP
|
protein folding in endoplasmic reticulum
|
A protein folding process that takes place in the endoplasmic reticulum (ER). Secreted, plasma membrane and organelle proteins are folded in the ER, assisted by chaperones and foldases (protein disulphide isomerases), and additional factors required for optimal folding (ATP, Ca2+ and an oxidizing environment to allow disulfide bond formation).
|
HSPA5,
HSP90B1,
CALR,
CANX,
PDIA3,
ERO1B,
DNAJC10,
EMC1,
ERO1A,
EMC3
|
GO:0034976
|
BP
|
response to endoplasmic reticulum stress
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
|
BCL2L11,
PARK2,
ERN1,
PPP1R15A,
FLOT1,
UBE4B,
EIF2S1,
P4HB,
THBS1,
CXCL8,
EEF2,
PDIA4,
HSP90B1,
ALOX15,
ATP2A2,
CEBPB,
ATF4,
PIK3R1,
PDIA3,
THBS4,
DDIT3,
UFM1,
PPP2CB,
EIF2B5,
TARDBP,
OS9,
PDIA5,
PDIA6,
TMEM259,
TXNDC11,
DNAJC10,
NRBF2,
ERO1A,
TRIB3,
MAP3K5,
ERP44,
FAM129A,
UBA5,
TMX4,
HYOU1
|
GO:0034982
|
BP
|
mitochondrial protein processing
|
The peptide cleavage of mitochondrial proteins, including cleavage contributing to their import.
|
OMA1
|
GO:0034983
|
BP
|
peptidyl-lysine deacetylation
|
The removal of an acetyl group from an acetylated lysine residue in a peptide or protein.
|
HDAC4,
SIRT2,
HDAC6,
HDAC9
|
GO:0035019
|
BP
|
somatic stem cell population maintenance
|
Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
|
POLR2D,
KLF4,
LDB2,
LRP5,
RAF1,
FGF2,
KIT,
SKI,
TDGF1,
POLR2E,
POLR2A,
POLR2B,
POLR2I,
PBX1,
STAT3,
YAP1,
ZFP36L2,
SOX9,
POLR2J,
POLR2K,
POLR2G,
POLR2L,
POU5F1,
SOX4,
KLF10,
SMAD4,
CUL4A,
HES1,
SMAD2,
SFRP1,
EPAS1,
LIN28A,
ELF5
|
GO:0035020
|
BP
|
regulation of Rac protein signal transduction
|
Any process that modulates the frequency, rate or extent of Rac protein signal transduction.
|
OGT,
SSX2IP
|
GO:0035021
|
BP
|
negative regulation of Rac protein signal transduction
|
Any process that stops, prevents, or reduces the frequency, rate or extent of Rac protein signal transduction.
|
ARAP3,
STMN3
|
GO:0035022
|
BP
|
positive regulation of Rac protein signal transduction
|
Any process that activates or increases the frequency, rate or extent of Rac protein signal transduction.
|
KRAS,
CAMK2D,
ALS2
|
GO:0035023
|
BP
|
regulation of Rho protein signal transduction
|
Any process that modulates the frequency, rate or extent of Rho protein signal transduction.
|
ARHGEF10,
FLOT1,
PLEKHG5,
FARP2,
RAF1,
BCR,
VAV1,
ARHGDIA,
ARHGDIB,
SOS1,
SOS2,
ARHGEF5,
ABR,
TIAM1,
MYO9B,
ARHGEF7,
ITSN1,
ARHGEF16,
DNMBP,
FGD6,
PREX2,
NET1,
FGD2,
MCF2L2,
ARHGEF28,
ARHGEF39,
ARHGEF2,
ARHGEF26,
FGD4,
SPATA13,
ALS2,
PLEKHG2,
ECT2,
ARHGEF10L,
ARHGEF4,
ARHGEF3,
ITSN2,
VAV3,
FARP1
|
GO:0035024
|
BP
|
negative regulation of Rho protein signal transduction
|
Any process that stops, prevents, or reduces the frequency, rate or extent of Rho protein signal transduction.
|
ARHGAP42,
ITGB1,
ITGA3,
ADRA1A,
BCL6,
CUL3,
KANK1,
FLCN,
ARAP3,
KCTD13,
DLC1
|
GO:0035025
|
BP
|
positive regulation of Rho protein signal transduction
|
Any process that activates or increases the frequency, rate or extent of Rho protein signal transduction.
|
COL3A1,
APOA1,
PDGFRB,
F2R,
F2RL1,
RAC1,
AKAP13,
ADGRG1
|
GO:0035026
|
BP
|
leading edge cell differentiation
|
The process in which relatively unspecialized cells acquire specialized structural and/or functional features of leading edge cells, cells at the front of a migrating epithelial sheet.
|
JUN,
DAB2
|
GO:0035036
|
BP
|
sperm-egg recognition
|
The initial contact step made between the sperm plasma membrane and outer layer of the egg during fertilization.
|
SPAM1
|
GO:0035048
|
BP
|
splicing factor protein import into nucleus
|
The directed movement of a pre-mRNA splicing factor from the cytoplasm into the nucleus, across the nuclear membrane.
|
TNPO3
|
GO:0035050
|
BP
|
embryonic heart tube development
|
The process whose specific outcome is the progression of the embryonic heart tube over time, from its formation to the mature structure. The heart tube forms as the heart rudiment from the heart field.
|
CTNNB1,
GJA5,
HHEX,
FOXC1,
SOX17,
IFT122,
NDRG4
|
GO:0035051
|
BP
|
cardiocyte differentiation
|
The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of a cell that will form part of the cardiac organ of an individual.
|
BMP2
|
GO:0035054
|
BP
|
embryonic heart tube anterior/posterior pattern specification
|
The establishment, maintenance and elaboration of cell differentiation that results in the anterior/posterior subdivision of the embryonic heart tube. In Drosophila this results in subdivision of the dorsal vessel into to the posterior heart proper and the anterior aorta.
|
BMP2,
GATA4
|
GO:0035058
|
BP
|
nonmotile primary cilium assembly
|
The assembly of a primary cilium which contains a variable array of axonemal microtubules but does not contain molecular motors. Nonmotile primary cilia are found on many different cell types and function as sensory organelles that concentrate and organize sensory signaling molecules.
|
CSNK1D,
PCM1,
TMEM107,
BBS7,
BBS1,
BBS10,
PIBF1,
CEP89,
BBS2,
CENPJ,
MKKS,
MKS1,
CC2D2A,
FAM179B
|
GO:0035063
|
BP
|
nuclear speck organization
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of nuclear specks, a class of nuclear body in which splicing factors are localized.
|
SRPK2
|
GO:0035065
|
BP
|
regulation of histone acetylation
|
Any process that modulates the frequency, rate or extent of the addition of an acetyl group to a histone protein.
|
FLCN,
PYGO2,
EID1
|
GO:0035066
|
BP
|
positive regulation of histone acetylation
|
Any process that activates or increases the frequency, rate or extent of the addition of an acetyl group to a histone protein.
|
SNAI2,
TADA2A,
RPS6KA5,
TGFB1,
IL1B,
MAPK3,
BRCA1,
TADA2B,
FOXP3,
BRD7,
PPARGC1A,
RUVBL2
|
GO:0035067
|
BP
|
negative regulation of histone acetylation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of an acetyl group to a histone protein.
|
SNCA,
BRCA1,
SET,
TWIST1,
FOXP3,
NOC2L
|
GO:0035082
|
BP
|
axoneme assembly
|
The assembly and organization of an axoneme, the bundle of microtubules and associated proteins that forms the core of cilia (also called flagella) in eukaryotic cells and is responsible for their movements.
|
TTLL1,
RSPH4A,
C6orf165,
CFAP46,
RSPH1,
CC2D2A,
FAM179B
|
GO:0035087
|
BP
|
siRNA loading onto RISC involved in RNA interference
|
The transfer of small interfering RNA molecules (siRNAs) from the Dicer family of enzymes that cleave the double-stranded RNA, onto the nuclease-containing RNA-initiated silencing complex (RISC), in the context of RNA interference.
|
AGO2,
DICER1
|
GO:0035088
|
BP
|
establishment or maintenance of apical/basal cell polarity
|
Any cellular process that results in the specification, formation or maintenance polarization of a cell's architecture along its apical/basal axis so that the apical and basal regions of the cell have different membrane, extracellular matrix and sub-membrane cellular components.
|
CDC42
|
GO:0035089
|
BP
|
establishment of apical/basal cell polarity
|
The specification and formation of the polarity of a cell along its apical/basal axis.
|
PRKCI,
FSCN1
|
GO:0035092
|
BP
|
sperm chromatin condensation
|
The progressive compaction of the spermatid chromatin so that it reaches a level of condensation that is not compatible with nuclear activities such as transcription or DNA replication.
|
SRPK1
|
GO:0035093
|
BP
|
spermatogenesis, exchange of chromosomal proteins
|
The replacement of somatic histones within sperm chromatin with sperm-specific histones or protamines with unique DNA-binding properties, resulting in condensation of the sperm chromatin.
|
PSME4
|
GO:0035094
|
BP
|
response to nicotine
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus.
|
KCNK1,
PENK,
EDN1,
HMOX1,
BCL2,
DRD2,
CREB1,
VCAM1,
CNR1,
CHRNA7,
STAR,
ATP1A2,
ABAT,
LYPD1,
HDAC2,
SLC7A11
|
GO:0035095
|
BP
|
behavioral response to nicotine
|
Any process that results in a change in the behavior of an organism as a result of a nicotine stimulus.
|
CHRNB1,
CHRNA5,
CHRNA7,
PPARA
|
GO:0035105
|
BP
|
sterol regulatory element binding protein import into nucleus
|
The transfer of a sterol regulatory element binding protein (SREBP) into the nucleus, across the nuclear membrane, in response to altered levels of one or more lipids. SREBPs are transcription factors that bind sterol regulatory elements (SREs), DNA motifs found in the promoters of target genes.
|
LMNA
|
GO:0035108
|
BP
|
limb morphogenesis
|
The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping.
|
GLI3,
PTCH1,
ZNF141,
PCSK5
|
GO:0035112
|
BP
|
genitalia morphogenesis
|
The process in which the anatomical structures of genitalia are generated and organized. The genitalia are the organs of reproduction or generation, external and internal.
|
CTNNB1
|
GO:0035115
|
BP
|
embryonic forelimb morphogenesis
|
The process, occurring in the embryo, by which the anatomical structures of the forelimb are generated and organized. The forelimbs are the front limbs of an animal, e.g. the arms of a human.
|
SHOX2,
ALDH1A2,
RECK,
CTNNB1,
WNT3,
CACNA1C,
RUNX2,
TWIST1,
NIPBL,
RDH10,
OSR1,
LNP,
IFT122,
ZNF358
|
GO:0035116
|
BP
|
embryonic hindlimb morphogenesis
|
The process, occurring in the embryo, by which the anatomical structures of the hindlimbs are generated and organized. The hindlimbs are the posterior limbs of an animal.
|
BMP4,
CTNNB1,
NOTCH1,
AFF3,
WNT3,
GNAS,
ZBTB16,
TWIST1,
GNAS,
OSR1,
PITX2,
CHD7
|
GO:0035128
|
BP
|
post-embryonic forelimb morphogenesis
|
The process, occurring after embryonic development, by which the anatomical structures of the forelimb are generated and organized. The forelimbs are the front limbs of an organism.
|
ATRX
|
GO:0035136
|
BP
|
forelimb morphogenesis
|
The process in which the anatomical structures of the forelimb are generated and organized. The forelimbs are the front limbs of an animal, e.g. the arms of a human.
|
HOXD10,
GDF5,
ZBTB16,
NIPBL,
RNF165,
SALL3
|
GO:0035137
|
BP
|
hindlimb morphogenesis
|
The process in which the anatomical structures of the hindlimb are generated and organized.
|
HOXD10,
BMPR1A,
GDF5,
PTCH1,
SALL3
|
GO:0035148
|
BP
|
tube formation
|
Creation of the central hole of a tube in an anatomical structure through which gases and/or liquids flow.
|
ITGB1BP1,
BCL2L11,
VEGFA,
NOTCH1,
SDCCAG8,
ATOH8
|
GO:0035162
|
BP
|
embryonic hemopoiesis
|
The stages of blood cell formation that take place within the embryo.
|
KIT,
TAL1,
KITLG,
TGFBR2,
PBX1,
HIF1A,
SH2B3
|
GO:0035166
|
BP
|
post-embryonic hemopoiesis
|
The stages of blood cell formation that take place after completion of embryonic development.
|
KLF4,
ERCC1,
MYO1E
|
GO:0035176
|
BP
|
social behavior
|
Behavior directed towards society, or taking place between members of the same species. Occurs predominantly, or only, in individuals that are part of a group.
|
TBX1,
BRINP1,
KRAS,
TH,
OXTR,
PTEN,
DLG4,
MAPK8IP2,
EIF4EBP2,
NLGN4X,
DNAJC9,
PTCHD1,
MKKS,
NRXN1
|
GO:0035194
|
BP
|
posttranscriptional gene silencing by RNA
|
Any process of posttranscriptional gene inactivation (silencing) mediated by small RNA molecules that may trigger mRNA degradation or negatively regulate translation.
|
TNRC6A,
TNRC6C,
AGO4,
AGO2,
TNRC6B
|
GO:0035195
|
BP
|
gene silencing by miRNA
|
Downregulation of gene expression through the action of microRNAs (miRNAs), endogenous 21-24 nucleotide small RNAs processed from stem-loop RNA precursors (pre-miRNAs). Once incorporated into a RNA-induced silencing complex (RISC), miRNAs can downregulate gene expression by either of two posttranscriptional mechanisms: endolytic cleavage of mRNA cleavage or translational repression, usually accompanied by poly-A tail shortening and subsequent degradation of the mRNA.
|
CNOT1,
EIF6,
TNRC6A,
AJUBA,
TNRC6C,
LIMD1,
CNOT7,
CNOT6
|
GO:0035196
|
BP
|
production of miRNAs involved in gene silencing by miRNA
|
Cleavage of stem-loop RNA precursors into microRNAs (miRNAs), a class of small RNAs that primarily silence genes by blocking the translation of mRNA transcripts into protein.
|
PRKRA,
AGO4,
AGO2,
DICER1
|
GO:0035229
|
BP
|
positive regulation of glutamate-cysteine ligase activity
|
Any process that activates or increases the activity of glutamate-cysteine ligase, typically by lowering its sensitivity to inhibition by glutathione and by increasing its affinity for glutamate.
|
GCLM
|
GO:0035234
|
BP
|
ectopic germ cell programmed cell death
|
Programmed cell death of an errant germ line cell that is outside the normal migratory path or ectopic to the gonad. This is an important mechanism of regulating germ cell survival within the embryo.
|
IL1A,
IL1B,
KIT,
KITLG,
PRKDC,
BAX
|
GO:0035235
|
BP
|
ionotropic glutamate receptor signaling pathway
|
A series of molecular signals initiated by glutamate binding to a glutamate receptor on the surface of the target cell, followed by the movement of ions through a channel in the receptor complex. Ends with regulation of a downstream cellular process, e.g. transcription.
|
APP,
GRIA4,
GRIN2A,
CLN3,
CPEB4
|